U.S. naloxone market is estimated to be valued at USD 550.4 Mn in 2024 and is expected to reach USD 1,086.1 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031. Increasing prevalence of drug overdoses, rising healthcare expenditure, government initiatives to curtail opioid crisis, and introduction of generic drugs can drive the market growth during the forecast period.
To learn more about this report, request sample copy
The naloxone market is expected to witness growth due to increasing incidence of opioid abuse disorders and overdose deaths in the U.S. Growing awareness regarding overdose emergencies and availability of various delivery forms such as auto-injectors and nasal sprays for emergency treatment can boost adoption of naloxone.
Opioid Overdose Epidemic
Growing opioid overdose epidemic in the U.S. can drive the naloxone market growth. Naloxone is a lifesaving medication that can rapidly reverse opioid overdoses. As more lives are being lost to opioid overdoses, the need for widespread access and administration of Naloxone has never been greater. According to the data published by Centers for Disease Control and Prevention, over 93,000 people died of drug overdoses in 2020, with majority of deaths being caused by synthetic opioids including fentanyl. As per the data from CDC, overdose deaths had increased almost 30% from 2019 to 2020, underlining the severity of the crisis. In response to this public health emergency, government agencies and community organizations across many U.S. states have stepped up efforts to make Naloxone more available to people at risk as well as to family members and friends of people suffering from addiction. Naloxone distribution programs have been established, and standing orders issued, allowing pharmacists to dispense Naloxone without an individual prescription. Several states have also passed legislation granting legal protection to bystanders who administer Naloxone. Such policy measures have significantly bolstered the penetration of Naloxone across communities. Moreover, educational programs about opioid overdose prevention and the use of Naloxone have raised awareness.
Government initiatives to expand access
The U.S government has taken several initiatives to expand access to naloxone, and this drives the naloxone market growth. Naloxone is an opioid antagonist that is used to reverse opioid overdoses, and it can save lives during an overdose emergency. The ongoing opioid crisis in the U.S. compelled government agencies to focus on increasing the availability of naloxone nationwide. For example, through programs like State Opioid Response (SOR) grants, Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded billions in funds to state governments to support opioid treatment and prevention efforts. This funding will be used to exapand naloxone distribution and teach overdose prevention education. As a result, all 50 U.S. states now have standing orders or other policies that allow pharmacists to dispense naloxone without an individual prescription. Community-based programs partnering with health departments, police and EMS have also received funding to set up naloxone distribution sites across cities and towns. These efforts are steadily increasing access to and utilization of naloxone. According to the data from SAMHSA, the number of naloxone kits distributed through their funded programs had increased from under 700,000 in 2017 to over 2.6 million in 2020. As per CDC Provisional Data, EMS administrations of naloxone for suspected opioid overdoses doubled from just under 50,000 in 2016 to over 140,000 in 2021.
U.S. Naloxone Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients